These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4087006)

  • 1. Bethanechol decreases reaction time in senile dementia of the Alzheimer type.
    Davous P; Lamour Y
    J Neurol Neurosurg Psychiatry; 1985 Dec; 48(12):1297-9. PubMed ID: 4087006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cholinergic and anticholinergic drugs on short-term memory in Alzheimer's dementia: a neuropsychological and computerized electroencephalographic study.
    Agnoli A; Martucci N; Manna V; Conti L; Fioravanti M
    Clin Neuropharmacol; 1983; 6(4):311-23. PubMed ID: 6661730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraventricular bethanechol in Alzheimer's disease: a continuing controversy.
    Whitehouse PJ
    Neurology; 1988 Feb; 38(2):307-8. PubMed ID: 2893315
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraventricular bethanechol infusion for Alzheimer's disease: results of double-blind and escalating-dose trials.
    Penn RD; Martin EM; Wilson RS; Fox JH; Savoy SM
    Neurology; 1988 Feb; 38(2):219-22. PubMed ID: 2893314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of muscarinic acetylcholine receptors in cultured guinea pig pancreatic acini.
    Hootman SR; Brown ME; Williams JA; Logsdon CD
    Am J Physiol; 1986 Jul; 251(1 Pt 1):G75-83. PubMed ID: 2425639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of parkinsonism by intraventricular bethanechol in a patient with Alzheimer's disease.
    Fox JH; Bennett DA; Goetz CG; Penn RD; Savoy S; Clasen R; Wilson RS
    Neurology; 1989 Sep; 39(9):1265. PubMed ID: 2570380
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer's disease.
    Harbaugh RE; Roberts DW; Coombs DW; Saunders RL; Reeder TM
    Neurosurgery; 1984 Oct; 15(4):514-8. PubMed ID: 6149490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebroventricular bethanechol chloride infusion in Alzheimer's disease. Results of a collaborative double-blind study.
    Harbaugh RE; Reeder TM; Senter HJ; Knopman DS; Baskin DS; Pirozzolo F; Chui HC; Shetter AG; Bakay RA; Leblanc R
    J Neurosurg; 1989 Oct; 71(4):481-6. PubMed ID: 2571689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory and attention in patients with senile dementia of the Alzheimer type and in normal elderly subjects.
    Lines CR; Dawson C; Preston GC; Reich S; Foster C; Traub M
    J Clin Exp Neuropsychol; 1991 Sep; 13(5):691-702. PubMed ID: 1955525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery to the brain by central infusion: clinical application in patients with Alzheimer's disease.
    Harbaugh RE
    Int Clin Psychopharmacol; 1986 Jan; 1(1):77-83. PubMed ID: 2881962
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholinergic hyperactivity and negative symptoms: behavioral effects of physostigmine in normal controls.
    Tandon R; Greden JF; Haskett RF
    Schizophr Res; 1993 Mar; 9(1):19-23. PubMed ID: 8461267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebroventricular bethanechol for Alzheimer's disease. Variable dose-related responses.
    Read SL; Frazee J; Shapira J; Smith C; Cummings JL; Tomiyasu U
    Arch Neurol; 1990 Sep; 47(9):1025-30. PubMed ID: 1975738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic cholinergic receptor subtype on frog esophageal peptic cells: binding and secretion studies.
    Dickinson KE; Matsumoto H; Anderson W; Pruitt RE; Uemura N; Hirschowitz BI
    J Pharmacol Exp Ther; 1988 Sep; 246(3):879-86. PubMed ID: 2901489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct cerebrospinal fluid infusion of bethanechol chloride in Alzheimer's disease: use of an implantable continuous infusion device.
    Reeder TM; Harbaugh RE
    J Neurosurg Nurs; 1985 Jun; 17(3):184-9. PubMed ID: 2861263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebroventricular cholinergic drug administration in Alzheimer's disease: preliminary results of a double-blind study.
    Harbaugh RE
    J Neural Transm Suppl; 1987; 24():271-7. PubMed ID: 2890709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of Baralgan and hyoscine-N-methyl bromide in the treatment of intestinal and renal colicy pain.
    Benyajati C
    J Med Assoc Thai; 1986 Oct; 69(10):569-73. PubMed ID: 3819615
    [No Abstract]   [Full Text] [Related]  

  • 17. Transmitter-replacement therapy in Alzheimer's disease using intracerebroventricular infusions of receptor agonists.
    Gauthier S; Leblanc R; Robitaille Y; Quirion R; Carlsson G; Beaulieu M; Bouchard R; Dastoor D; Ervin F; Gauthier L
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):394-402. PubMed ID: 2878712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of the muscarinic receptor in rabbit gastric smooth muscle.
    Tomomasa T; Hyman PE; Hsu CT; Jing J; Snape WJ
    Am J Physiol; 1988 May; 254(5 Pt 1):G680-6. PubMed ID: 2896463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of scopolamine on stimulus sensitivity and response bias in a visual vigilance task.
    Wesnes K; Warburton DM
    Neuropsychobiology; 1983; 9(2-3):154-7. PubMed ID: 6621852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic receptors in the cerebellar vermis modulate the gain of the vestibulospinal reflexes in decerebrate cats.
    Andre P; Pompeiano O; Manzoni D; D'Ascanio P
    Arch Ital Biol; 1992 Jul; 130(3):213-45. PubMed ID: 1354955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.